Renal alterations in prediabetic rats with periodontitis

Journal of Periodontology

Volumn 79, Issue 4, 2008, Pages 684-690

  Pontes Andersen, Carla C ^a   Holmstrup, Palle ^a   Buschard, Karsten ^b   Flyvbjerg, Allan ^c  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Diabetes mellitus; Diabetic kidney disease; Periodontitis; Prediabetes; Rats

Indexed keywords

COLLAGEN TYPE 4; CONNECTIVE TISSUE GROWTH FACTOR; CREATININE; FIBRONECTIN; IMMEDIATE EARLY PROTEIN; MEMBRANE PROTEIN; MESSENGER RNA; NEPHRIN; SIGNAL PEPTIDE; SOMATOMEDIN BINDING PROTEIN; TRANSFORMING GROWTH FACTOR BETA; VASCULAR ENDOTHELIAL GROWTH FACTOR A, RAT; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2;

ALBUMINURIA; ANIMAL; ARTICLE; COMPARATIVE STUDY; GLOMERULUS; HYPERTROPHY; IMPAIRED GLUCOSE TOLERANCE; KIDNEY; KIDNEY DISEASE; MALE; ORGAN SIZE; PATHOLOGY; PATHOPHYSIOLOGY; PERIODONTITIS; RANDOMIZATION; RAT; URINE; ZUCKER RAT;

ALBUMINURIA; ANIMALS; COLLAGEN TYPE IV; CREATININE; FIBRONECTINS; HYPERTROPHY; IMMEDIATE-EARLY PROTEINS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY; KIDNEY DISEASES; KIDNEY GLOMERULUS; MALE; MEMBRANE PROTEINS; ORGAN SIZE; PERIODONTITIS; PREDIABETIC STATE; RANDOM ALLOCATION; RATS; RATS, ZUCKER; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 42949119166     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2008.070433     Document Type: Article

References (35)

1. Ruggenenti P, Remuzzi G. Nephropathy of type-2 diabetes mellitus. J Am Soc Mephrol 1998;9:2157-2169.
2. Flyvbjerg A. Putative pathophysiological role of growth factors and cytokines in experimental diabetic kidney disease. Diabetologia 2000;43:1205-1223.
3. Flyvbjerg A, Dagnaes-Hansen F, De Vriese AS, Schrijvers BFF, Tilton RQ, Rasch R. Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody. Diabetes 2002;51:3090-3094.
4. Schrijvers BF, De Vriese AS, Flyvbjerg A. From hyperglycemia to diabetic kidney disease: The role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines. Endocr Rev 2004;25:971-1010.
5. Kowluru RA, Abbas SN, Odenbach S. Reversal of hyperglycemia and diabetic nephropathy: Effect of reinstitution of good metabolic control on oxidative stress in the kidney of diabetic rats. J Diabetes Complications 2004;18:282-288.
6. Pontes Andersen CC, Buschard K, Flyvbjerg A, Stoltze K, Holmstrup P. Periodontitis is associated with aggravation of pre-diabetes in Zucker fatty rats. J Periodontol 2007;78:559-565.
7. Kuroe A, Taniguchi A, Sekiguchi A, et al. Prevalence of periodontal bacterial infection in non-obese Japanese type 2 diabetic patients: Relationship with C-reactive protein and albuminuria. Horm Metab Res 2004;36:116-118.
8. Saremi A, Nelson RG, Tulloch-Reid M, et al. Periodontal disease and mortality in type 2 diabetes. Diabetes Care 2005;28:27-32.
9. Shultis WA, Weil EJ, Looker HC, et al. Effect of periodontitis on overt nephropathy and end-stage renal disease in type 2 diabetes. Diabetes Care 2007; 30:306-311.
10. Janssen U, Phillips AO, Floege J. Rodent models of nephropathy associated with type II diabetes. J Nephrol 1999;12:159-172.
11. Bjornsson MJ, Velschow S, Stoltze K, Havemose-Poulsen A, Schou S, Holmstrup P. The influence of diet consistence, drinking water and bedding on periodontal disease in Sprague-Dawley rats. J Periodontal Res 2003;38:543-550.
12. Grauballe MC, Bentzen BH, Bjornsson M, et al. The effect of spironolactone on experimental periodontitis in rats. J Periodontal Res 2005;40:212-217.
13. Jensen LJ, Denner L, Schrijvers BF, Tilton RG, Rasch R, Flyvbjerg A. Renal effects of a neutralising RAGE-antibody in long-term streptozotocin- diabetic mice. J Endocrinol 2006;188:493-501.
14. Weibel ER. Stereologic Methods: Practical Methods for Biological Morphometry. London: Academic Press; 1979:51-57.
15. Pagtalunan ME, Rasch R, Rennke HG, Meyer TW. Morphometric analysis of effects of angiotensin II on glomerular structure in rats. Am J Physiol 1995;268: F82-F88.
16. Gundersen HJG, Bagger P, Bendtsen TF, et al. The new stereological tools - Disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS 1988;96:857-881.
17. Lihn AS, Bruun JM, He GS, Pedersen SB, Jensen PF, Richelsen B. Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjects. Mol Cell Endocrinol 2004;219:9-15.
18. Seyer-Hansen K. Renal hypertrophy in experimental diabetes mellitus. Kidney Int 1983;23:643-646.
19. Bak M, Thomsen K, Christiansen T, Flyvbjerg A. Renal enlargement precedes renal hyperfiltration in early experimental diabetes in rats. J Am Soc Nephrol 2000; 11:1287-1292.
20. Coimbra TM, Janssen Cl, Grone HJ, et al. Early events leading to renal injury in obese Zucker (fatty) rats with type 11 diabetes. Kidney Int 2000;57:167-182.
21. Nyengaard JR, Rasch R. The impact of experimental diabetes mellitus in rats on glomerular capillary number and sizes. Diabetologia 1993;36:189-194.
22. Cooper ME, Vranes D, Youssef S, et al. Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes. Diabetes 1999;48:2229-2239.
23. Tsuchida K, Makita Z, Yamagishi S, et al. Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, OPB-9195. Diabetologia 1999;42:579-588.
24. Hamano Y, Grunkemeyer JA, Sudhakar A, et al. Determinants of vascular permeability in the kidney glomerulus. J Biol Chem 2002;277:31154-31162.
25. Riser BL, Denichilo M, Cortes P, et al. Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis. J Am Soc Nephrol 2000; 11:25-38.
26. Twigg SM, Cao Z, McLennan SV, et al. Renal connective tissue growth factor induction in experimental diabetes is prevented by aminoguanidine. Endocrinology 2002;143:4907-4915.
27. Tucker BJ, Rasch R, Blantz RC. Glomerular filtration and tubular reabsorption of albumin in preproteinuric and proteinuric diabetic rats. J Clin Invest 1993;92: 686-694.
28. Kshirsagar AV, Moss KL, Elter JR, Beck JD, Offenbacher S, Falk RJ. Periodontal disease is associated with renal insufficiency in the atherosclerosis risk in communities (ARIC) study. Am J Kidney Dis 2005;45: 650-657.
29. Beck JD, Elter JR, Heiss G, Couper D, Mauriello SM, Offenbacher S. Relationship of periodontal disease to carotid artery intima-media wall thickness: The atherosclerosis risk in communities (ARIC) study. Arterioscler Thromb Vasc Biol 2001;21:1816-1822.
30. Seinost G, Wimmer G, Skerget M, et al. Periodontal treatment improves endothelial dysfunction in patients with severe periodontitis. Am Heart J 2005;149:1050-1054.
31. Stuveling EM, Bakker SJL, Hillege HL, de Jong PE, Gans ROB, de Zeeuw D. Biochemical risk markers: A novel area for better prediction of renal risk? Nephrol Dial Transplant 2005;20:497-508.
32. Forner L, Larsen T, Kilian M, Holmstrup P. Incidence of bacteremia after chewing, tooth brushing and scaling in individuals with periodontal inflammation. J Clin Periodontol 2006;33:401-407.
33. Angeli F, Verdecchia P, Pellegrino C, et al. Association between periodontal disease and left ventricle mass in essential hypertension. Hypertension 2003;41:488-492.
34. Franek E, Blach A, Vitula A, et al. Association between chronic periodontal disease and left ventricular hypertrophy in kidney transplant recipients. Transplantation 2005;80:3-5.
35. Kurtz TW, Morris RC, Pershadsingh HA. The Zucker fatty rat as a genetic model of obesity and hypertension. Hypertension 1989;13:896-901.